COST-EFFECTIVENESS OF BISPHOSPHONATES IN THE PREVENTION OF FRACTURES IN OSTEOPENIC POSTMENOPAUSAL WOMEN IN COLOMBIA

被引：0
|
作者：
Diaz-Puentes, M. [1 ]
Rosselli, D. [2 ]
Colon-Pena, C. -A. [3 ]
机构：
[1] Hosp Univ San Ignacio, Bogota, Colombia
[2] Pontificia Univ Javeriana, Bogota, Colombia
[3] Fdn Santafe Bogota, Bogota, Colombia
来源：
AGING CLINICAL AND EXPERIMENTAL RESEARCH | 2022年 / 34卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
P195
引用
收藏
页码：S138 / S139
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women
    Schousboe, JT
    Nyman, JA
    Kane, RL
    Ensrud, KE
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (09) : 734 - 741
  • [2] Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women
    Kanis, JA
    Borgstrom, F
    Johnell, O
    Jonsson, B
    [J]. OSTEOPOROSIS INTERNATIONAL, 2004, 15 (11) : 862 - 871
  • [3] Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women
    J. A. Kanis
    F. Borgstrom
    O. Johnell
    B. Jonsson
    [J]. Osteoporosis International, 2004, 15 : 862 - 871
  • [4] COST-EFFECTIVENESS OF ALENDRONATE THERAPY FOR OSTEOPENIC POSTMENOPAUSAL WOMEN IN JAPAN
    Moriwaki, K.
    Komaba, H.
    Noto, S.
    Yanagisawa, S.
    Inoue, H.
    Takeshi, T.
    Fukagawa, M.
    Takahashi, H. E.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A46 - A47
  • [5] Cost-Effectiveness of Alendronate for the Treatment of Osteopenic Postmenopausal Women in Japan
    Moriwaki, Kensuke
    Komaba, Hirotaka
    Noto, Shinichi
    Yanagisawa, Shinichiro
    Takiguchi, Toru
    Inoue, Hiroki
    Toujo, Takeshi
    Fukagawa, Masafumi
    Takahashi, Hideaki E.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (02) : 395 - 403
  • [6] The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women
    Stevenson, M.
    Davis, S.
    Lloyd-Jones, M.
    Beverley, C.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2007, 11 (04) : 1 - +
  • [7] A cost-effectiveness model of tibolone as treatment for the prevention of osteoporotic fractures in postmenopausal women in Sweden
    Willis, M
    Ödegaard, K
    Persson, U
    Hedbrant, J
    Mellström, D
    Hammar, M
    [J]. CLINICAL DRUG INVESTIGATION, 2001, 21 (02) : 115 - 127
  • [8] A Cost-Effectiveness Model of Tibolone as Treatment for the Prevention of Osteoporotic Fractures in Postmenopausal Women in Sweden
    Michael Willis
    Knut Ödegaard
    Ulf Persson
    Johan Hedbrant
    Dan Mellström
    Mats Hammar
    [J]. Clinical Drug Investigation, 2001, 21 : 115 - 127
  • [9] A COST-EFFECTIVENESS MODEL OF BAZEDOXIFENE VS. RALOXIFENE FOR THE PREVENTION OF FRACTURES IN SPANISH POSTMENOPAUSAL WOMEN
    Darba, Josep
    Perez-Alvarez, Nuria
    Kaskens, Lisette
    Racketa, Jill
    Rejas, Javier
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 256 - 257
  • [10] Cost-effectiveness of teriparatide (Forteo) in the prevention of osteoporotic fractures among men and postmenopausal women in Australia
    Graham-Clarke, PL
    Lees, M
    Wolthers, T
    Thiebaud, D
    Price, N
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 297 - 297
12345